September 4, 2007 - Siemens Medical Solutions expanded its portfolio of ultrasound applications with the syngo Arterial Health Package (AHP) that calculates cardiovascular risks by measuring the carotid intima media thickness and determining the so-called vascular age, the relative age of the vessel.

Together with other factors, such as cholesterol values and blood pressure, the physician can use the results of syngo AHP to better assess a patient's myocardial or stroke-related risk and establish an individual prevention and treatment plan.

The syngo Arterial Health Package (AHP) determines the vascular age, the advance of atherosclerotic burden and displays it to the patient. Knowing the vascular age supports the physician in more accurately determining the personal risk of a patient to develop coronary heart disease, in rendering a prognosis and in developing a prevention and therapy plan. The new ultrasound application provides a measurement of the intima media thickness of the carotid, the innermost layer of the carotid vessel wall. An abnormal widening of the intima media is considered evidence of threatening or already existing arteriosclerosis.

In addition, syngo AHP takes into account the Atherosclerosis Risk in Communities (ARIC) database to determine the risk index from the Framingham Heart Study using the relative vascular age rather than the chronological age of the patient.

For more information: www.medical.siemens.com


Additional Content

News | RSNA

Nov. 9, 2026 — At the 2026 Radiological Society of North America (RSNA) Annual Meeting, Samsung Healthcare will ...

Time November 09, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | Ultrasound Women's Health

Sept. 3, 2026 — Royal Philips has introduced the eV14-2v transvaginal transducer, expanding its obstetrics and ...

Time September 04, 2026
arrow
News | Breast Imaging

Aug. 20, 2026 — Candelis, Inc. has announced a collaboration with GE HealthCare to support the distribution of Candelis ...

Time August 24, 2026
arrow
News | Clinical Trials

Aug.12, 2026 — Mendaera Inc. has announced results from a peer-reviewed study showing that its FDA-cleared Focalist ...

Time August 17, 2026
arrow
Subscribe Now